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Introduction
The elderly, who represent 12% of
the population, have been reported to take
30% of all prescription medications.'
Higher prescription drug use has been re-
ported for persons who are older, female,
and in poorer health; who have more im-
paired activities of daily living; and who
have a secondary reimbursement source
(e.g., health insurance or Medicaid).
Those who have a higher income, who are
employed, orwho have had more years of
education, and those who are Black have
been found to be less likely to use pre-
scribed medications.'-11 The finding of
lower medication drug use among
Blacks'1 is particularly perplexing be-
cause, by most criteria, their health is
poorer12; consequently, their use of med-
ications would be expected to be greater
than that of non-Blacks.
Although the elderly are also fre-
quent users of nonprescription drugs,5 in-
formation on the factors associated with
the use of such drugs is scantier than that
for prescription drugs. In general, re-
ported findings indicate that women and
those who are NVhite are more likely to be
taking nonprescription drugs, but the as-
sociation of nonprescription drug use with
age is unclear.4,5"10 1' A number of reasons
for nonprescription drug use have been
proposed: these drugs may be used by
persons who perceive medical care to be
unavailable, by those who are more anx-
ious, or as a substitute for or in conjunc-
tion with prescription drugs.2"13-5 Factors
consistently reported to be associated
with prescription drug use (e.g., income,
education, socioeconomic level, health
status) are not consistently related to use
of nonprescription drugs.16
Few studies have examined racial
differences in drug use while taking into
account interrelated predictors of such
use.13-15,17-22 The main purpose of the pre-
sent study, then, was to examine determi-
nants of the use of prescription and non-
prescription drugs by elderly Black and
White community residents using a mul-
tivariate approach. Second, we wished to
determine whether the model that ex-
plains prescription drug use would also ex-
plain nonprescription drug use.
Methods
Sample
The data come from the in-home
baseline survey (1986 to 1987) of the Duke
Established Populations for Epidemio-
logic Studies of the Elderly.23'24 In brief,
the study sample consists of a stratified
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probability household sample of 4163
community residents aged 65 or older liv-
ing in five adjacent urban and rural coun-
ties in the Piedmont area of North Caro-
lina. To increase statistical precision,
Blacks were oversampled, constituting
54% of those interviewed compared with
35% of the same age population. Analysis
weights take initial nonresponse into ac-
count, correct for the oversampling of
Blacks, and allow inference to the five-
county area at the time of the survey. The
Duke study was approved by the Duke
University Medical Center Institutional
Review Board, and informed consentwas
obtained from each participant before data
were gathered.
The present analysis excluded 30
subjects who were neither Black nor
White, and 160 subjects with only proxy
data since information on their self-as-
sessed health status was unavailable.
Hence, the analysis data set included 2152
Black and 1821 White elderly, of whom
1727 (80.3%) and 1588 (87.2%), respec-
tively, responded to each item analyzed.
Data Collection
Information was obtained by means
of a 90-minute, in-person interview in the
home. The interview schedule has been
published.23 Relevant available data in-
clude (1) demographic characteristics; (2)
limited information on health conditions
(i.e., the presence of a heart condition,
stroke, cancer, diabetes, hypertension),
self-assessed health (a single item), and
physical health functioning; and (3) mea-
sures of use of selected health care serv-
ices and professionals, income, and health
insurance.
The name, strength, and dosage form
of each medication taken in the prior 2
weeks or to be taken as needed were re-
corded."
Drug Data Entiy
Each drugwas assigned a unique four-
digit generic code from the DPICS and IN-
DPICS coding system5 using a locally de-
veloped interactive data entry program,"
and each was further numerically coded to
indicate whether it was a prescription or
nonprescription product. Reliability of
drug data entry, which was tested by re-
entering a 5% sample, was found to be
highly satisfactory, with the rate of coding
errors estimated to be 1.63% (95% confi-
dence interval = 0.71%, 2.55%).
Model Development
A health care services use modeP25
was chosen to explore prescription and
nonprescription drug use. Specifically,
use of medications was expected to be in-
fluenced by demographic characteristics,
health status, and factors that facilitate or
hinder drug use.
The demographic characteristics in-
cluded race (Black/White), sex, age and
education (both in years), marital status
(married/not currently married), and cur-
rent residence in an urban or rural area.
Health status was assessed by three
measures. The first, a medical status
score, summarized the medical impact of
five common chronic health conditions
(heart condition, stroke, cancer, diabetes,
and hypertension). These physical health
conditionswere the only ones present that
had any medication-related relevance.
The medical status score reflected the av-
eraged evaluations (summed over all five
conditions) made by 36 clinicians experi-
enced in the care of the elderly; the eval-
uations were made regarding the extent to
which each condition had an impact on
health status. In making these evalua-
tions, the clinicians considered all avail-
able information. For instance, in rating
heart condition, they took into account
any report of heart attack and, if there
were any such reports, factored in how
many, how recently, and whether there
was a related hospitalization. The manner
ofdevelopment ofthe medical status scale
ensured that it had content validity; it also
had construct validity, summary scores
being related to selected aspects of health
services use, self-rated health, and activ-
ities of daily living in the expected man-
ner. Thus, this measure is valid and max-
imizes the information available.
The two additional measures of
health status included self-rated health (a
4-point scale in which 0 = poor and
3 = excellent) and a measure of func-
tional physical health (three items of the
Rosow and Breslau scale,26 in which the
score was the number of items the subject
had difficulty performing, with missing
values imputed where possible).
Items facilitating or hindering drug
use included the number of outpatient vis-
its in the past 12 months to a medical pro-
fessional for a physical health problem,
whether the same health care professional
was usually seen on each visit, and hos-
pitalization in the previousyear. Addition-
ally, they included not being on Medicaid
(which in North Carolina pays for pre-
scription medications); enrollment in
Medicare (which financially facilitates ac-
cess to medical care and hence to receipt
of a prescription); supplementary health
insurance (which may pay toward pre-
scription medications); and adequacy of
income.
StatisticalAnalysis
Descriptive statistics were calculated
separately for Blacks and Whites. To ex-
amine the impact of missing data, use of
prescription and nonprescription drugs by
full and partial responders was compared
using Student's t test. For all other vari-
ables (demographic, health status,
facilitating/hindering characteristics), in-
formation on the individual comparisons
was combined and an omnibus test was
carried out (Fisher's Inverse Chi-Square
Method based on P values derived from
Wilcoxon's signed rank test or the
Kruskal-Wallis statistic).27
For prescription and nonprescription
drugs, the proportions of Black and White
respondents using at least one drug were
compared using chi-square tests. Compar-
ison of mean drug use by race was made
using Student's t test.
Multivariate models were con-
structed using forward linear regression,
introducing blocks ofdemographic, health
status, and facilitatinghindering variables
successively as predictors of the number
of drugs used. Separately for prescription
and nonprescription drug use, models
were run for Blacks, Whites, and both
races combined; the latter model included
an indicator variable for race. All models
used analysis weights. Initial models were
run in SAS, using procedure REG28; final
models considered sample design effects
andwere implemented in SURREGR.29-X
To detenmine the impact ofexcluding
partial responders from the models, all but
the final stage ofeach series ofmodelswas
run with partial responders included
where they were not automatically de-
leted by the software.
Results
Sample Characteristics
Table 1 shows the characteristics of
responders in the current sample. For
both Blacks and Whites, those who re-
sponded to each item were less impaired
than those who did not (P < .0001). On
average, partial responders reported more
prescription and fewer nonprescription
drugs than full responders. They tended to
be older, less educated, in poorer func-
tional and self-assessed health, and more
likely to have been hospitalized in the pre-
vious year. If Black, they were less likely
to be married; if White, they were more
likely to be female and less likely to have
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supplementary health insurance. The ex-
clusion ofpartial responders from analysis
appears to have had little impact on the
findings.
Prevalence and Extent ofDiug Use,
Bqth Types
In the present study, 76% of White
and 74% of elderly Black community res-
idents took at least one prescription drug,
a nonsignificant difference. However,
Black users took significantly fewer pre-
scription drugs (mean = 2.79, SD = 1.75)
than did White users (mean = 3.19,
SD = 2.20; t = 5.53, df = 2693;
P < .0001). Only 67% of Blacks com-
pared with 76% of Whites (X2 = 43.26,
df = 1; P < .0001) reported taking non-
prescription drugs. Of those reporting
such use, Blacks again took significantly
fewer nonprescription drugs (mean = 1.69,
SD = 1.01) than did Whites (mean = 1.89,
SD = 1.18; t = 4.86, df = 2804;
P < .0001).
Although here the health status of
Blacks appears to be similar to that of
Whites, Blacks use fewer drugs of either
type. They are also less likely than their
White counterparts to be married and to
have supplementary health insurance;
they also have less education and are in
more straitened economic circumstances.
Predictors ofPrescnption Drug Use
For elderly White community resi-
dents (Table 2), demographic characteris-
tics explained a minimum amount ofvari-
ance (0.8%), those with poor education
being heavier consumers of prescription
drugs. When health status was also con-
sidered, an additional 30% of variance in
prescription drug use was explained. For
each health measure, poorer standing in-
dicated greater prescription drug use. A
further 6.4% ofvariancewas explained by
facilitating/hindering characteristics, for a
total of 37.2% of variance explained. Of
the latter characteristics, the number of
visits to a physician, the same physician
seen on each occasion, overnight hospi-
talization in the previous year, and the
presence of Medicaid and of supplemen-
tary health insurance were significant pre-
dictors of prescription drug use. With the
inclusion ofthe facilitating characteristics,
level of education lost its significance but
area of residence became important:
amongWhite elderly, urban area residents
were likely to be taking more prescription
drugs than rural area residents.
For elderly Black community resi-
dents (Table 3), demographic characteris-
tics explained 3.2% of the variance in pre-
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scription drug use, with only sex being
statistically significant: Black women
were higher users ofprescription drugs (or
rather, Black men were particularly low
users). When health status was also con-
sidered, 22.9% of the variance was ex-
plained. Poor health status as assessed by
each of the three measures predicted in-
creased prescription drug use. Addition of
the facilitating/hindering variables in-
creased the amount ofvariance explained
to 31.5%, with making more frequent vis-
its to a physician, consistently seeing the
same physician, having Medicaid, and
having Medicare being significant predic-
tors of prescription drug use.
Finally, a model was run that in-
cluded both Black and White elderly res-
idents (tables available from the authors).
This model explained 36.6% of the vari-
ance in prescription drug use. Race per se
was statistically significant and contrib-
uted 1.3% to the overall variance. All
characteristics found to be significant pre-
dictors of prescription drug use in the
separate models for White elderly and
Black elderly (with the exception ofMedi-
care, significant for Black elderly, and
Medigap insurance, significant for White
elderly)were statistically signicant. Race
interaction effects showed that Black el-
derly with impainnents on the Rosow-
Breslau26 and Black elderly women who
had been hospitalized in the previous year
were likely to use fewer drugs than their
White counterparts, whereas White el-
derlywomen who reported their health to




Among elderly White community
residents (Table 4), allvariables combined
explained 6.0% of the variance (demo-
graphic characteristics explained 2.8%,
and the addition of health status explained
5.4%). Female sex, urban residence,
younger age, more education, poor self-
rated health and medical status, and an
increased number of physician visits were
statistically significant predictors.
The explanatory power of the model
was less for elderly Black community res-
idents (Table 5). In all, 4.8% ofthevariance
in nonprescription drug usewas explained.
The only important characteristics were
being female, considering one's health to
be poorer, having supplemental health in-
surance, and not being on Medicaid.
A model that included information
from both Black and White elderly resi-
dents explained 6.4% of the variance in
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nonprescription drug use. Race per sewas
statistically significant, contributing 0.7%.
All characteristics found to be statistically
significant in either the nonprescription
model for White elderly or that for Black
elderlywere also statistically significant in
the combined race model, with the excep-
tion of Medicaid and supplemental health
insurance.
Discussion
These data allow us to compare the
characteristics of Black and White elderly
who represent all socioeconomic levels
and who live in both urban and rural set-
tings in a defined geographic area. As
such, our data are unique, permitting com-
parisons not hitherto feasible. While de-
scriptive information on the prescription
and nonprescription drug use of minority
groups exists,8"11 studies ofdrug use in the
elderly based on multivariate techniques
have been restricted by the relative youth
of sample members (under age 65), small
sample sizes, limited representativeness,
and lack of information on race.6,10,14
We found that, with other factors
controlled, race made a statistically signif-
icant, if substantively small, contribution
to explaining prescription drug use. The
multivariate health care services use
model explained up to 37% ofthe variance
in prescription drug use. Demographic
characteristics had little explanatory
power although, in the absence of other
data, they seemed to act as proxies for
health status and use of health care serv-
ices. Similarly, the importance of other
characteristics (e.g., living in an urban
area where transportation may be easier
and pharmacies more numerous) only be-
came evident with concomitant consider-
ation of additional information.
It has been suggested that access to
prescription drugs is based on formal health
system factors.13,14 Certainly here, prescrip-
tion drug use is predominantly explained by
health status and use ofthe health care sys-
tem, just those factors that can result in a
prescription.31 It is also important to note
that having Medicaid (which pays for drugs
for the medically indigent)was a significant
predictor of prescription drug use.
Although the primary determinants
of prescription drug use (i.e., poor health
status, more frequent medical visits, and
the same physician seen on those visits)
are similar for elderly Black and White
community residents, there are some
unique differences. For example, living in
an urban area and recent overnight hos-
pitalization are important in explaining
prescription drug use for elderly Whites
but not for elderly Blacks.
In common with other investiga-
tors,1'3- we also find that the health serv-
ices use model explains nonprescription
drug use poorly. Access to nonprescrip-
tion drugs is not bound by medical or leg-
islative constraints. Unlike the case for
prescription drug use, demographic char-
acteristics were particularly important:
being White, female, younger, better ed-
ucated, and an urban area resident were
predictive of nonprescription use. Indeed,
these are the people towhom nonprescrip-
tion drug use is targeted. While poorer
health might also be relevant, it is unclear
from these data whether nonprescription
drugs substituted for or supplemented the
use of prescription drugs.
The nonprescription use models for
Black elderly differ from those for White
elderly in that they reflect concern about
health, particularly bywomen, and about
the availability of some money to spend
on it.
In the present study, race per se is a
significant predictor of both kinds of drug
use. Black elderly, particularly Black
men, are likely to take fewer prescription
drugs. However, the reasons for this are
unclear. Possibly physicians prescribe dif-
ferently for Black elderly as compared
with White elderly.'0 Another possibility
is that Black elderly may face restrictions
in economic access to drugs. A larger pro-
portion of White elderly than of Black el-
derly have supplementary health insur-
ance, which may pay for prescription
drugs. Conversely, a higher proportion of
Black elderly are on Medicaid, and while
Medicaid facilitates the use ofprescription
drugs, not all physicians will accept Med-
icaid patients and the program places re-
strictions on the number of reimbursable
drugs that can be received in a given time
interval. Other financial restrictions may
also be present. Thus, the presence of
Medicaid modifies but does not close the
racial gap in prescription drug use. With
respect to nonprescription drug use, Black
elderly, in particular Black men, are again
low users, but elderly Black users of non-
prescription drugs appear to have a finan-
cial background comparable to that of
White elderly.
The present study has some limita-
tions. For one thing, current analysis is
based on cross-sectional data. We are as-
suming that poor health leads to the use of
medical care services, which results in
prescriptions and the use of prescription
drugs. The reverse is possible but is dis-
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tinctly less likely. For another thing, in-
formation from some sample members is
incomplete; however, this appears to have
had little effect on the findings, except per-
haps to make them slightly more conser-
vative. More important, the lack of infor-
mation on psychiatric conditions and on
other physical conditions such as arthritis
may have decreased the explanatory
power of the models, particularly regard-
ing nonprescription drugs. Lastly, current
analyses also do not address the issue of
appropriateness of drug use. That will be
the focus of a future study.
Despite these limitations, the current
study provides population-based informa-
tion for both Black and White elderly res-
idents, showing that the use of prescrip-
tion drugs is largely governed by the same
characteristics for each group (although
unique race characteristics still exist). In
addition, the study points to the impor-
tance of the Medicaid program in equal-
izing access to prescription drugs, and it
shows that an alternative model is needed
to explain the use of nonprescription
drugs. [1
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